Furthermore, although increased risks of adverse clinical events associated with Hb fluctuation were reported in hemodialysis patients,17 there is limited information in patients with NDD-CKD regarding various adverse clinical events.18,19. Here, GSTM1 is linked to chronic kidney disease.